BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18182258)

  • 1. Effect of preparation method on properties of orally disintegrating tablets made by phase transition.
    Kuno Y; Kojima M; Ando S; Nakagami H
    Int J Pharm; 2008 May; 355(1-2):87-92. PubMed ID: 18182258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of rapidly disintegrating tablets manufactured by phase transition of sugar alcohols.
    Kuno Y; Kojima M; Ando S; Nakagami H
    J Control Release; 2005 Jun; 105(1-2):16-22. PubMed ID: 15955365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the type of lubricant on the characteristics of orally disintegrating tablets manufactured using the phase transition of sugar alcohol.
    Kuno Y; Kojima M; Nakagami H; Yonemochi E; Terada K
    Eur J Pharm Biopharm; 2008 Aug; 69(3):986-92. PubMed ID: 18396020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
    Sano S; Iwao Y; Kimura S; Itai S
    Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orally Disintegrating Tablet Manufacture via Direct Powder Compression Using Cellulose Nanofiber as a Functional Additive.
    Nakamura S; Fukai T; Sakamoto T
    AAPS PharmSciTech; 2021 Dec; 23(1):37. PubMed ID: 34950985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapidly disintegrating tablets prepared by the wet compression method: mechanism and optimization.
    Bi Y; Yonezawa Y; Sunada H
    J Pharm Sci; 1999 Oct; 88(10):1004-10. PubMed ID: 10514347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
    Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
    Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of orally disintegrating tablets with taste-masking function: masking effect in granules prepared with correctives using the dry granulation method and evaluation of tablets prepared using the taste-masked granules.
    Kawano Y; Ito A; Sasatsu M; Machida Y
    Yakugaku Zasshi; 2010 Jan; 130(1):81-6. PubMed ID: 20046070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation design of a novel fast-disintegrating tablet.
    Mizumoto T; Masuda Y; Yamamoto T; Yonemochi E; Terada K
    Int J Pharm; 2005 Dec; 306(1-2):83-90. PubMed ID: 16257154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of oral dosage form for elderly patients: use of agar as base of rapidly disintegrating oral tablets.
    Ito A; Sugihara M
    Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2132-6. PubMed ID: 8945779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation study for orally disintegrating tablet using partly pregelatinized starch binder.
    Mimura K; Kanada K; Uchida S; Yamada M; Namiki N
    Chem Pharm Bull (Tokyo); 2011; 59(8):959-64. PubMed ID: 21804239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preparation and evaluation of taste masked orally disintegrating tablets with granules made by the wet granulation method].
    Kawano Y; Ito A; Sasatsu M; Machida Y; Onishi H
    Yakugaku Zasshi; 2010 Dec; 130(12):1737-42. PubMed ID: 21139401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Holistic Multi Evidence Approach to Study the Fragmentation Behaviour of Crystalline Mannitol.
    Koner JS; Rajabi-Siahboomi A; Bowen J; Perrie Y; Kirby D; Mohammed AR
    Sci Rep; 2015 Nov; 5():16352. PubMed ID: 26553127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The preparation of orally disintegrating tablets using a hydrophilic waxy binder.
    Abdelbary G; Prinderre P; Eouani C; Joachim J; Reynier JP; Piccerelle P
    Int J Pharm; 2004 Jul; 278(2):423-33. PubMed ID: 15196646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and evaluation of dried yeast tablets using different techniques.
    Al-Mohizea AM; Ahmed MO; Al-jenoobi FI; Mahrous GM; Abdel-Rahman AA
    Eur J Pharm Biopharm; 2007 Aug; 67(1):253-9. PubMed ID: 17270410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A completely solvent-free process for the improvement of erythritol compactibility.
    Hoashi Y; Tozuka Y; Takeuchi H
    Int J Pharm; 2013 Oct; 455(1-2):132-7. PubMed ID: 23891654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Establishment of a Novel Method to Evaluate Water Permeation Rates by Combining the Dynamic Contact Angle and Thermographic Approach: Significance of Disintegration Properties of Orally Disintegrating Tablets].
    Suzuki T; Kurano T; Kanazawa T; Suzuki N
    Yakugaku Zasshi; 2020; 140(8):1071-1080. PubMed ID: 32741865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of orally disintegrating tablets of Perphenazine/hydroxypropyl-β-cyclodextrin inclusion complex.
    Wang L; Zeng F; Zong L
    Pharm Dev Technol; 2013; 18(5):1101-10. PubMed ID: 22759202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity.
    Bi Y; Sunada H; Yonezawa Y; Danjo K; Otsuka A; Iida K
    Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2121-7. PubMed ID: 8945778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and evaluation of microwave-treated orally disintegrating tablets containing polymeric disintegrant and mannitol.
    Sano S; Iwao Y; Noguchi S; Kimura S; Itai S
    Int J Pharm; 2013 May; 448(1):132-41. PubMed ID: 23524122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.